0001567619-21-004471.txt : 20210218 0001567619-21-004471.hdr.sgml : 20210218 20210218192658 ACCESSION NUMBER: 0001567619-21-004471 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210216 FILED AS OF DATE: 20210218 DATE AS OF CHANGE: 20210218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Claflin Bruce L. CENTRAL INDEX KEY: 0001403694 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 21651427 MAIL ADDRESS: STREET 1: 7035 RIDGE ROAD CITY: HANOVER STATE: MD ZIP: 21076 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 doc1.xml FORM 4 X0306 4 2021-02-16 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001403694 Claflin Bruce L. C/O IDEXX LABORATORIES, INC. ONE IDEXX DRIVE WESTBROOK ME 04092 1 0 0 0 Common Stock 2021-02-16 4 M 0 5902 85 A 6206 D Common Stock 2021-02-16 4 M 0 1125 160.28 A 7331 D Common Stock 2021-02-16 4 S 0 6745 536.8856 D 586 D Common Stock 2021-02-16 4 S 0 586 537.1931 D 0 D Non-Qualified Stock Option (right-to-buy) 85 2021-02-16 4 M 0 5902 D 2026-05-03 Common Stock 5902 0 D Non-Qualified Stock Option (right-to-buy) 160.28 2021-02-16 4 M 0 1125 D 2027-05-02 Common Stock 1125 1921 D Represents the weighted average price of the shares sold ranging from a low of $536.13 to a high of $537.125 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $537.15 to a high of $537.23 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the date of the 2017 annual meeting of shareholders. Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on May 3, 2018. Not applicable. /s/ Lily J. Lu, Attorney-in-Fact for Bruce L. Claflin 2021-02-18